Last 12 months
Inside the activity.
3 purchase rows · 60 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 2 |
| Dec 2025 | 0 | 1 |
| Jan 2026 | 0 | 2 |
| Feb 2026 | 2 | 2 |
| Mar 2026 | 1 | 3 |
| Apr 2026 | 0 | 5 |
| May 2026 | 0 | 3 |
| Jun 2026 | 0 | 3 |
| Jul 2026 | 0 | 4 |
| Aug 2026 | 0 | 5 |
| Sep 2026 | 0 | 13 |
| Oct 2026 | 0 | 17 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| July 25, 2017 Filed Jul 27, 2017 20:23 UTC |
Richman MichaelDirector
|
GrantStock Option (right to buy) · Derivative | 3,288 | $0.00 Strike: $5.64 | $0.00 |
DisclosureSEC source: 0000899243-17-019252 · doc4.xml · derivative · entry 1 Richman Michael · CIK 0001366265 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,288 Underlying: Common Stock · 3,288 shares Expires 2027-07-25 Read SEC document |
| July 25, 2017 Filed Jul 28, 2017 00:27 UTC |
Khuong Chau QuangDirector · 10% owner
|
GrantStock Option (right to buy) · Derivative | 5,018 | $0.00 Strike: $5.64 | $0.00 |
DisclosureSEC source: 0000899243-17-019253 · doc4.xml · derivative · entry 1 Khuong Chau Quang · CIK 0001609405 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,018 Underlying: Common Stock · 5,018 shares Expires 2027-07-25 F1 · security: The Reporting Person is an employee of OrbiMed Advisors LLC ("Advisors") and is obligated to transfer any shares issued under equity grants made to him by the Issuer, or the economic benefits thereof, to Advisors for the ultimate benefit of OrbiMed Private Investments III, LP and OrbiMed Associates III, LP. Read SEC document |
| May 22, 2017 Filed May 25, 2017 00:03 UTC |
GERAGHTY JAMES ADirector
|
GrantStock Option (right to buy) · Derivative | 30,000 | $0.00 Strike: $3.94 | $0.00 |
DisclosureSEC source: 0000899243-17-014270 · doc4.xml · derivative · entry 1 GERAGHTY JAMES A · CIK 0001239746 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,000 Underlying: Common Stock · 30,000 shares Expires 2017-05-22 F1 · security: The stock option will vest in four equal quarterly installments on each of June 30, 2017, September 30, 2017, December 31, 2017 and March 31, 2018, subject to the Reporting Person's continued service as a director. F1 · derivative.exercise_date: The stock option will vest in four equal quarterly installments on each of June 30, 2017, September 30, 2017, December 31, 2017 and March 31, 2018, subject to the Reporting Person's continued service as a director. Read SEC document |
| April 25, 2017 Filed Apr 27, 2017 18:06 UTC |
Richman MichaelDirector
|
GrantStock Option (right to buy) · Derivative | 7,821 | $0.00 Strike: $2.32 | $0.00 |
DisclosureSEC source: 0000899243-17-011040 · doc4.xml · derivative · entry 1 Richman Michael · CIK 0001366265 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,821 Underlying: Common Stock · 7,821 shares Expires 2027-04-25 Read SEC document |
| April 25, 2017 Filed Apr 27, 2017 22:09 UTC |
Khuong Chau QuangDirector · 10% owner
|
GrantStock Option (right to buy) · Derivative | 10,546 | $0.00 Strike: $2.32 | $0.00 |
DisclosureSEC source: 0000899243-17-011043 · doc4.xml · derivative · entry 1 Khuong Chau Quang · CIK 0001609405 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,546 Underlying: Common Stock · 10,546 shares Expires 2027-04-25 F1 · security: The Reporting Person is an employee of OrbiMed Advisors LLC ("Advisors") and is obligated to transfer any shares issued under equity grants made to him by the Issuer, or the economic benefits thereof, to Advisors for the ultimate benefit of OrbiMed Private Investments III, LP and OrbiMed Associates III, LP. Read SEC document |
| April 21, 2017 Filed May 9, 2017 18:30 UTC |
KIRITSY CHRISTOPHER PDirector
|
Exercise / conversionStock Option (right to buy) · Derivative | 5,000 | $0.00 Strike: $1.59 | $0.00 |
DisclosureSEC source: 0000899243-17-012544 · doc4.xml · derivative · entry 2 KIRITSY CHRISTOPHER P · CIK 0001261156 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,000 Underlying: Common Stock · 30,000 shares Expires 2026-09-20 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The stock option vests in four equal quarterly installments on each of September 30, 2016, December 31, 2016, March 31, 2017 and June 30, 2017, subject to the Reporting Person's continued service as a director. Read SEC document |
| April 21, 2017 Filed May 9, 2017 18:30 UTC |
KIRITSY CHRISTOPHER PDirector
|
Exercise / conversionCommon Stock | 5,000 | $1.59 | $7,950.00 |
DisclosureSEC source: 0000899243-17-012544 · doc4.xml · nonDerivative · entry 1 KIRITSY CHRISTOPHER P · CIK 0001261156 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 23, 2017 Filed Mar 6, 2017 11:52 UTC |
Yoder Stephen S.Director · Chief Executive Officer
|
GrantStock Option (Right to buy) · Derivative | 434,350 | $0.00 Strike: $1.99 | $0.00 |
DisclosureSEC source: 0000899243-17-006559 · doc4.xml · derivative · entry 1 Yoder Stephen S. · CIK 0001645577 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 434,350 Underlying: Common Stock · 434,350 shares Expires 2027-02-23 F1 · derivative.exercise_date: The option vests as to 25% of the option shares on January 1, 2018 and vests as to an additional 6.25% of the option shares at the end of each successive three-month period thereafter. Read SEC document |
| February 23, 2017 Filed Mar 6, 2017 11:50 UTC |
Matis LouisSee Remarks
|
GrantStock option (Right to buy) · Derivative | 145,000 | $0.00 Strike: $1.99 | $0.00 |
DisclosureSEC source: 0000899243-17-006558 · doc4.xml · derivative · entry 1 Matis Louis · CIK 0001650991 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 145,000 Underlying: Common Stock · 145,000 shares Expires 2027-02-23 F1 · derivative.exercise_date: The option vests as to 25% of the option shares on January 1, 2018 and vests as to an additional 6.25% of the option shares at the end of each successive three-month period thereafter. Read SEC document |
| January 25, 2017 Filed Jan 30, 2017 19:10 UTC |
KIRITSY CHRISTOPHER PDirector
|
GrantStock Option (right to buy) · Derivative | 20,000 | $0.00 Strike: $2.01 | $0.00 |
DisclosureSEC source: 0000899243-17-002209 · doc4.xml · derivative · entry 1 KIRITSY CHRISTOPHER P · CIK 0001261156 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,000 Underlying: Common Stock · 20,000 shares Expires 2027-01-25 F1 · derivative.exercise_date: The stock option will vest in four equal installments on each of March 31, June 30, September 30, and December 31, 2017. Read SEC document |
| January 25, 2017 Filed Jan 30, 2017 19:04 UTC |
ADAMS JULIANDirector
|
GrantStock Option (right to buy) · Derivative | 20,000 | $0.00 Strike: $2.01 | $0.00 |
DisclosureSEC source: 0000899243-17-002205 · doc4.xml · derivative · entry 1 ADAMS JULIAN · CIK 0001230486 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,000 Underlying: Common Stock · 20,000 shares Expires 2027-01-25 F1 · derivative.exercise_date: The stock option will vest in four equal installments on each of March 31, June 30, September 30, and December 31, 2017. Read SEC document |
| January 25, 2017 Filed Jan 30, 2017 19:02 UTC |
Prelack StevenDirector
|
GrantStock Option (right to buy) · Derivative | 20,000 | $0.00 Strike: $2.01 | $0.00 |
DisclosureSEC source: 0000899243-17-002202 · doc4.xml · derivative · entry 1 Prelack Steven · CIK 0001302315 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,000 Underlying: Common Stock · 20,000 shares Expires 2027-01-25 F1 · derivative.exercise_date: The stock option will vest in four equal installments on each of March 31, June 30, September 30, and December 31, 2017. Read SEC document |
| January 25, 2017 Filed Jan 30, 2017 19:02 UTC |
Richman MichaelDirector
|
GrantStock Option (right to buy) · Derivative | 20,000 | $0.00 Strike: $2.01 | $0.00 |
DisclosureSEC source: 0000899243-17-002203 · doc4.xml · derivative · entry 2 Richman Michael · CIK 0001366265 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,000 Underlying: Common Stock · 20,000 shares Expires 2027-01-25 F2 · derivative.exercise_date: The stock option will vest in four equal installments on each of March 31, June 30, September 30, and December 31, 2017. Read SEC document |
| January 25, 2017 Filed Jan 30, 2017 19:02 UTC |
Richman MichaelDirector
|
GrantStock Option (right to buy) · Derivative | 9,687 | $0.00 Strike: $2.01 | $0.00 |
DisclosureSEC source: 0000899243-17-002203 · doc4.xml · derivative · entry 1 Richman Michael · CIK 0001366265 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,687 Underlying: Common Stock · 9,687 shares Expires 2027-01-25 F1 · shares: The option award was issued to the Reporting Person, who elected to take shares in lieu of cash compensation for services as a director and committee member, pursuant to the Issuer's non-employee director compensation plan. Read SEC document |
| January 25, 2017 Filed Jan 31, 2017 00:01 UTC |
Khuong Chau QuangDirector · 10% owner
|
GrantStock Option (right to buy) · Derivative | 20,000 | $0.00 Strike: $2.01 | $0.00 |
DisclosureSEC source: 0000899243-17-002201 · doc4.xml · derivative · entry 2 Khuong Chau Quang · CIK 0001609405 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,000 Underlying: Common Stock · 20,000 shares Expires 2027-01-25 F3 · derivative.exercise_date: The stock option will vest in four equal installments on each of March 31, June 30, September 30, and December 31, 2017. Read SEC document |
| January 25, 2017 Filed Jan 31, 2017 00:01 UTC |
Khuong Chau QuangDirector · 10% owner
|
GrantStock Option (right to buy) · Derivative | 10,313 | $0.00 Strike: $2.01 | $0.00 |
DisclosureSEC source: 0000899243-17-002201 · doc4.xml · derivative · entry 1 Khuong Chau Quang · CIK 0001609405 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,313 Underlying: Common Stock · 10,313 shares Expires 2027-01-25 F1 · security: The Reporting Person is an employee of OrbiMed Advisors LLC ("Advisors") and is obligated to transfer any shares issued under equity grants made to him by the Issuer, or the economic benefits thereof, to Advisors for the ultimate benefit of OrbiMed Private Investments III, LP and OrbiMed Associates III, LP. F2 · shares: The option award was issued to the Reporting Person, who elected to take shares in lieu of cash compensation for services as a director and committee member, pursuant to the Issuer's non-employee director compensation plan. Read SEC document |
| January 25, 2017 Filed Jan 31, 2017 00:05 UTC |
BIZZARI JEAN-PIERREDirector
|
GrantStock Option (right to buy) · Derivative | 20,000 | $0.00 Strike: $2.01 | $0.00 |
DisclosureSEC source: 0000899243-17-002208 · doc4.xml · derivative · entry 1 BIZZARI JEAN-PIERRE · CIK 0001630914 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,000 Underlying: Common Stock · 20,000 shares Expires 2027-01-25 F1 · derivative.exercise_date: The stock option will vest in four equal installments on each of March 31, June 30, September 30, and December 31, 2017. Read SEC document |
| November 28, 2016 Filed Nov 30, 2016 20:24 UTC |
Knopf ClaudeChief Business Officer
|
GrantCommon Stock · Derivative | 500,000 | $0.00 Strike: $1.45 | $0.00 |
DisclosureSEC source: 0000899243-16-034609 · doc4.xml · derivative · entry 1 Knopf Claude · CIK 0001690684 · Chief Business Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 500,000 Underlying: Common Stock · 500,000 shares Expires 2026-11-28 F1 · derivative.exercise_date: The option vests as to 25% of the option shares on November 28, 2017 and vests as to an additional 6.25% of the option shares at the end of each successive three-month period thereafter until November 28, 2020. Read SEC document |
| October 25, 2016 Filed Oct 27, 2016 19:27 UTC |
Richman MichaelDirector
|
GrantStock Option (right to buy) · Derivative | 9,656 | $0.00 Strike: $1.64 | $0.00 |
DisclosureSEC source: 0000899243-16-032393 · doc4.xml · derivative · entry 1 Richman Michael · CIK 0001366265 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,656 Underlying: Common Stock · 9,656 shares Expires 2026-10-25 Read SEC document |
| October 25, 2016 Filed Oct 27, 2016 23:28 UTC |
Khuong Chau QuangDirector · 10% owner
|
GrantStock Option (right to buy) · Derivative | 10,279 | $0.00 Strike: $1.64 | $0.00 |
DisclosureSEC source: 0000899243-16-032395 · doc4.xml · derivative · entry 1 Khuong Chau Quang · CIK 0001609405 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,279 Underlying: Common Stock · 10,279 shares Expires 2026-10-25 F1 · security: The Reporting Person is an employee of OrbiMed Advisors LLC ("Advisors") and is obligated to transfer any shares issued under equity grants made to him by the Issuer, or the economic benefits thereof, to Advisors for the ultimate benefit of OrbiMed Private Investments III, LP and OrbiMed Associates III, LP. Read SEC document |
| September 20, 2016 Filed Sep 22, 2016 10:44 UTC |
KIRITSY CHRISTOPHER PDirector
|
GrantStock Option (right to buy) · Derivative | 30,000 | $0.00 Strike: $1.59 | $0.00 |
DisclosureSEC source: 0000899243-16-029695 · doc4.xml · derivative · entry 1 KIRITSY CHRISTOPHER P · CIK 0001261156 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,000 Underlying: Common Stock · 30,000 shares Expires 2026-09-20 F1 · security: The stock option will vest in four equal quarterly installments on each of September 30, 2016, December 31, 2016, March 31, 2017 and June 30, 2017, subject to the Reporting Person's continued service as a director. F1 · derivative.exercise_date: The stock option will vest in four equal quarterly installments on each of September 30, 2016, December 31, 2016, March 31, 2017 and June 30, 2017, subject to the Reporting Person's continued service as a director. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.